Protocol for a randomised controlled trial to evaluate the effectiveness of the diabetes community exercise and education programme (DCEP) for long-term management of diabetes

BMJ Open
Leigh HaleChristopher Higgs

Abstract

Type 2 diabetes is common in Māori and Pacific peoples and in those living in areas of high socioeconomic deprivation in New Zealand (NZ). People with type 2 diabetes often have multimorbidity, which makes their diabetes management more complex. The Diabetes Community Exercise and Education Programme (DCEP) is an interprofessional, patient-centred, whānau (family)-supported package of care specifically developed to engage with Māori and Pacific people and those living in deprived areas. We have previously demonstrated the feasibility and acceptability of the DCEP. This study aims to determine the effectiveness and cost-effectiveness of the DCEP through a pragmatic randomised controlled trial (RCT). 220 adults (age ≥35 years) with type 2 diabetes will be recruited from general practices in the lower South Island of NZ (Dunedin and Invercargill) to participate in an RCT. Participants will be randomised to intervention (DCEP) and control (usual care) groups. The DCEP participants will have their exercise goals agreed on with a physiotherapist and nurse and will attend two 90 min exercise and education sessions per week for 12 weeks. The primary outcome measure is blood glucose control (glycated haemoglobin). Secondary outcome meas...Continue Reading

References

Nov 25, 1998·Diabetic Medicine : a Journal of the British Diabetic Association·D SimmonsB Gatland
Aug 24, 1999·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·C BradleyR Plowright
Jul 18, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·A BagustC J Currie
Dec 17, 2002·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·F CamachoR Balkrishnan
Jan 30, 2007·Diabetes Care·Elaine H MorratoPatrick W Sullivan
Dec 7, 2007·The International Journal of Behavioral Nutrition and Physical Activity·Ralph MaddisonElaine Rush
Feb 16, 2008·BMJ : British Medical Journal·M J DaviesUNKNOWN Diabetes Education and Self Management for Ongoing and Newly Diagnosed Collaborative
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Mar 26, 2010·BMC Medicine·Kenneth F SchulzUNKNOWN CONSORT Group
Nov 19, 2010·Medicine and Science in Sports and Exercise·Sheri R ColbergUNKNOWN American Diabetes Association
Mar 12, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·M F JanssenA S Pickard
Apr 12, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M HerdmanX Badia
Nov 8, 2011·Diabetes Research and Clinical Practice·Hajime MaedaUNKNOWN ASSET-K Study group
Nov 22, 2014·Journal of Human Kinetics·Alen KapidžićAlija Biberovic
Dec 11, 2014·Journal of Diabetes and Metabolic Disorders·Ruchika GuglaniJaspal Singh Sandhu
Mar 21, 2015·BMJ : British Medical Journal·Graham F MooreJanis Baird
Mar 31, 2016·Australian and New Zealand Journal of Public Health·Christopher HarrisonHelena Britt
May 18, 2016·Implementation Science : IS·M Alexis KirkLaura Damschroder
Aug 2, 2016·Journal of Primary Health Care·Chris HiggsLeigh Hale
May 2, 2018·International Journal of Environmental Research and Public Health·Dorothy W NdwigaDavid Simmons
Aug 3, 2018·Journal of Primary Health Care·Tim StokesFiona Doolan Noble

❮ Previous
Next ❯

Software Mentioned

DESMOND
REDCap
Stata
R
TIDieR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.